MiRNA 138 has been shown to be up-regulated in invasive breast cancer cell lines [53], and may act as a tumor suppressor in breast, endometrial and pancreatic carcinomas via regulation of neutrophil gelatinase-associated lipocalin (NGAL); a gene up-regulated in some cancers [54]. The gene discussed is LCN2; the disease is neoplasm.